We are live on ! Find out more
PRPH

ProPhase Labs
PRPH

Delisted

PRPH was delisted on the 2nd of January, 2026.

Back to rankings

16 hedge funds and large institutions have $2.71M invested in ProPhase Labs in 2014 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 4 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

56% more capital invested

Capital invested by funds: $1.73M → $2.71M (+$979K)

0% more first-time investments, than exits

New positions opened: 2 | Existing positions closed: 2

11% less funds holding

Funds holding: 18 → 16 (-2)

25% less repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 4

Holders
16
Holders Change
-2
Holders Change %
-11.11%
% of All Funds
0.43%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
3
Reduced
4
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
+$944K
2
Citadel Advisors
Citadel Advisors
Florida
+$18.1K
3
Renaissance Technologies
Renaissance Technologies
New York
+$5.53K
4
Deutsche Bank
Deutsche Bank
Germany
+$1.81K

Top Sellers

Rank Fund Capital Flow
1
Bank of New York Mellon
Bank of New York Mellon
New York
-$34.6K
2
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
-$30.3K
3
VKH
Virtu KCG Holdings
New York
-$21K
4
Goldman Sachs
Goldman Sachs
New York
-$3.35K
5
TRCT
Tower Research Capital (TRC)
New York
-$747

PRPH Hedge Fund Activity: Q4 2014 in Review

16 of the 3,764 institutional investors tracked by Wall St. Rank reported a position in ProPhase Labs (PRPH) for Q4 2014, worth a combined $2.71M — up 56% from $1.73M a quarter earlier.

Fund positioning in PRPH was balanced in Q4 2014: 2 funds opened new positions, 2 closed out, 3 added to existing stakes and 4 trimmed.

The largest buyer was Morgan Stanley, adding an estimated $944K. The largest seller was Bank of New York Mellon, cutting an estimated $34.6K.

  • 16 institutional investors held ProPhase Labs (PRPH) as of Q4 2014, down from 18 in Q3 2014.
  • Funds reported $2.71M of ProPhase Labs stock for Q4 2014, up 56% quarter-over-quarter.
  • 2 funds opened new ProPhase Labs positions in Q4 2014 and 2 closed out, a net change of 0 holders.
  • The largest ProPhase Labs buyer in Q4 2014 was Morgan Stanley, an estimated $944K added.
  • The largest ProPhase Labs seller in Q4 2014 was Bank of New York Mellon, an estimated $34.6K sold.

Based on aggregated 13F filings for Q4 2014.